chemotherapy: be better than radiotherapy

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.64
, regimen
Weight: 0.62
, modality
Weight: 0.61
, agent
Weight: 0.60
, prostate cancer
Weight: 0.59
Siblings gene therapy
Weight: 0.66
, breast cancer
Weight: 0.36
, dialysis
Weight: 0.36
, transplant
Weight: 0.34
, mastectomy
Weight: 0.34

Related properties

Property Similarity
be better than radiotherapy 1.00
be effective in cancer treatment 0.80
be better than dialysis 0.80
be vs iv chemotherapy 0.78
be given after mastectomy 0.77
get more funding than prostate 0.76
be more important than other cancer 0.76
be vs lumpectomy 0.76
be for just cancer 0.76
be better than hemodialysis 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.53
Rule weight: 0.66
Evidence weight: 0.99
Similarity weight: 0.80
Evidence: 0.85
Plausible(agent, be effective in cancer treatment)
Evidence: 0.05
¬ Typical(chemotherapy, be better than radiotherapy)

Plausibility inheritance from parent to child

0.03
Rule weight: 0.09
Evidence weight: 0.38
Similarity weight: 0.80
Evidence: 0.27
Plausible(chemotherapy, be better than radiotherapy)
Evidence: 0.85
¬ Plausible(agent, be effective in cancer treatment)

Remarkability exclusitivity betweem a parent and a child

0.27
Rule weight: 0.58
Evidence weight: 0.58
Similarity weight: 0.80
Evidence: 0.98
¬ Remarkable(chemotherapy, be better than radiotherapy)
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment)

Remarkability exclusitivity between siblings

0.05
Rule weight: 0.13
Evidence weight: 0.47
Similarity weight: 0.80
Evidence: 0.98
¬ Remarkable(chemotherapy, be better than radiotherapy)
Evidence: 0.54
¬ Remarkable(transplant, be better than dialysis)
0.04
Rule weight: 0.13
Evidence weight: 0.41
Similarity weight: 0.76
Evidence: 0.98
¬ Remarkable(chemotherapy, be better than radiotherapy)
Evidence: 0.60
¬ Remarkable(dialysis, be better than hemodialysis)
0.04
Rule weight: 0.13
Evidence weight: 0.36
Similarity weight: 0.76
Evidence: 0.98
¬ Remarkable(chemotherapy, be better than radiotherapy)
Evidence: 0.65
¬ Remarkable(breast cancer, be more important than other cancer)
0.04
Rule weight: 0.13
Evidence weight: 0.36
Similarity weight: 0.76
Evidence: 0.98
¬ Remarkable(chemotherapy, be better than radiotherapy)
Evidence: 0.66
¬ Remarkable(breast cancer, get more funding than prostate)
0.03
Rule weight: 0.13
Evidence weight: 0.28
Similarity weight: 0.76
Evidence: 0.98
¬ Remarkable(chemotherapy, be better than radiotherapy)
Evidence: 0.73
¬ Remarkable(mastectomy, be vs lumpectomy)

Remarkability from parent implausibility

0.34
Rule weight: 0.42
Evidence weight: 1.00
Similarity weight: 0.80
Evidence: 0.85
Plausible(agent, be effective in cancer treatment)
Evidence: 0.98
Remarkable(chemotherapy, be better than radiotherapy)
Evidence: 0.27
¬ Plausible(chemotherapy, be better than radiotherapy)

Remarkability from sibling implausibility

0.39
Rule weight: 0.60
Evidence weight: 0.81
Similarity weight: 0.80
Evidence: 0.27
Plausible(chemotherapy, be better than radiotherapy)
Evidence: 0.54
Remarkable(transplant, be better than dialysis)
Evidence: 0.56
¬ Plausible(transplant, be better than dialysis)
0.38
Rule weight: 0.60
Evidence weight: 0.83
Similarity weight: 0.76
Evidence: 0.27
Plausible(chemotherapy, be better than radiotherapy)
Evidence: 0.66
Remarkable(breast cancer, get more funding than prostate)
Evidence: 0.68
¬ Plausible(breast cancer, get more funding than prostate)
0.37
Rule weight: 0.60
Evidence weight: 0.82
Similarity weight: 0.76
Evidence: 0.27
Plausible(chemotherapy, be better than radiotherapy)
Evidence: 0.73
Remarkable(mastectomy, be vs lumpectomy)
Evidence: 0.93
¬ Plausible(mastectomy, be vs lumpectomy)
0.36
Rule weight: 0.60
Evidence weight: 0.78
Similarity weight: 0.76
Evidence: 0.27
Plausible(chemotherapy, be better than radiotherapy)
Evidence: 0.65
Remarkable(breast cancer, be more important than other cancer)
Evidence: 0.86
¬ Plausible(breast cancer, be more important than other cancer)
0.33
Rule weight: 0.60
Evidence weight: 0.71
Similarity weight: 0.76
Evidence: 0.27
Plausible(chemotherapy, be better than radiotherapy)
Evidence: 0.60
Remarkable(dialysis, be better than hemodialysis)
Evidence: 0.98
¬ Plausible(dialysis, be better than hemodialysis)

Salient implies Plausible

0.17
Rule weight: 0.28
Evidence weight: 0.59
Similarity weight: 1.00
Evidence: 0.27
Plausible(chemotherapy, be better than radiotherapy)
Evidence: 0.57
¬ Salient(chemotherapy, be better than radiotherapy)

Similarity expansion

0.65
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.78
Evidence: 0.98
Remarkable(chemotherapy, be better than radiotherapy)
Evidence: 0.95
¬ Remarkable(chemotherapy, be vs iv chemotherapy)
0.64
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.77
Evidence: 0.98
Remarkable(chemotherapy, be better than radiotherapy)
Evidence: 0.98
¬ Remarkable(chemotherapy, be given after mastectomy)
0.64
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.76
Evidence: 0.98
Remarkable(chemotherapy, be better than radiotherapy)
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)
0.63
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.77
Evidence: 0.05
Typical(chemotherapy, be better than radiotherapy)
Evidence: 0.04
¬ Typical(chemotherapy, be given after mastectomy)
0.56
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.78
Evidence: 0.05
Typical(chemotherapy, be better than radiotherapy)
Evidence: 0.17
¬ Typical(chemotherapy, be vs iv chemotherapy)
0.53
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.77
Evidence: 0.27
Plausible(chemotherapy, be better than radiotherapy)
Evidence: 0.26
¬ Plausible(chemotherapy, be given after mastectomy)
0.50
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.77
Evidence: 0.57
Salient(chemotherapy, be better than radiotherapy)
Evidence: 0.56
¬ Salient(chemotherapy, be given after mastectomy)
0.47
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.78
Evidence: 0.27
Plausible(chemotherapy, be better than radiotherapy)
Evidence: 0.41
¬ Plausible(chemotherapy, be vs iv chemotherapy)
0.47
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.78
Evidence: 0.57
Salient(chemotherapy, be better than radiotherapy)
Evidence: 0.69
¬ Salient(chemotherapy, be vs iv chemotherapy)
0.38
Rule weight: 0.85
Evidence weight: 0.59
Similarity weight: 0.76
Evidence: 0.57
Salient(chemotherapy, be better than radiotherapy)
Evidence: 0.94
¬ Salient(chemotherapy, be for just cancer)
0.24
Rule weight: 0.85
Evidence weight: 0.37
Similarity weight: 0.76
Evidence: 0.27
Plausible(chemotherapy, be better than radiotherapy)
Evidence: 0.87
¬ Plausible(chemotherapy, be for just cancer)
0.09
Rule weight: 0.85
Evidence weight: 0.14
Similarity weight: 0.76
Evidence: 0.05
Typical(chemotherapy, be better than radiotherapy)
Evidence: 0.90
¬ Typical(chemotherapy, be for just cancer)

Typical and Remarkable implies Salient

0.14
Rule weight: 0.14
Evidence weight: 0.98
Similarity weight: 1.00
Evidence: 0.57
Salient(chemotherapy, be better than radiotherapy)
Evidence: 0.05
¬ Typical(chemotherapy, be better than radiotherapy)
Evidence: 0.98
¬ Remarkable(chemotherapy, be better than radiotherapy)

Typical implies Plausible

0.46
Rule weight: 0.48
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.27
Plausible(chemotherapy, be better than radiotherapy)
Evidence: 0.05
¬ Typical(chemotherapy, be better than radiotherapy)

Typicality and Rermarkability incompatibility between a parent and a child

0.03
Rule weight: 0.51
Evidence weight: 0.08
Similarity weight: 0.80
Evidence: 0.98
¬ Remarkable(chemotherapy, be better than radiotherapy)
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)

Typicality and Rermarkability incompatibility between siblings

0.05
Rule weight: 0.14
Evidence weight: 0.53
Similarity weight: 0.76
Evidence: 0.98
¬ Remarkable(chemotherapy, be better than radiotherapy)
Evidence: 0.48
¬ Typical(mastectomy, be vs lumpectomy)
0.04
Rule weight: 0.14
Evidence weight: 0.40
Similarity weight: 0.80
Evidence: 0.98
¬ Remarkable(chemotherapy, be better than radiotherapy)
Evidence: 0.61
¬ Typical(transplant, be better than dialysis)
0.03
Rule weight: 0.14
Evidence weight: 0.31
Similarity weight: 0.76
Evidence: 0.98
¬ Remarkable(chemotherapy, be better than radiotherapy)
Evidence: 0.71
¬ Typical(breast cancer, get more funding than prostate)
0.02
Rule weight: 0.14
Evidence weight: 0.22
Similarity weight: 0.76
Evidence: 0.98
¬ Remarkable(chemotherapy, be better than radiotherapy)
Evidence: 0.80
¬ Typical(dialysis, be better than hemodialysis)
0.01
Rule weight: 0.14
Evidence weight: 0.11
Similarity weight: 0.76
Evidence: 0.98
¬ Remarkable(chemotherapy, be better than radiotherapy)
Evidence: 0.91
¬ Typical(breast cancer, be more important than other cancer)

Typicality inheritance from parent to child

0.04
Rule weight: 0.48
Evidence weight: 0.10
Similarity weight: 0.80
Evidence: 0.05
Typical(chemotherapy, be better than radiotherapy)
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)